Bianca Rocca/LinkedIn
Jun 29, 2026, 13:18
Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn about a recent article by Valeria Caso et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
”Delighted to share this just-released opinion by leading international experts addressing the current and evolving debate on Factor XI as a pharmacological target.
I hope you enjoy the article, and I wish everyone a great week!”
Title: Current opinion: the OCEANIC trial journey: from failure to breakthrough?
Authors: Valeria Caso, Hugo ten Cate, Isabelle C van Gelder
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’
-
Jun 29, 2026, 13:01Edward Lee Carter: Exploring Anticoagulation Paradox
-
Jun 29, 2026, 12:55Salvatore Massimo Petrina: When is it Truly Safe to Stop Anticoagulation after AF Ablation?
-
Jun 29, 2026, 12:44Sumedha Dash: Inspiring the Next Generation of Voluntary Blood Donors at CV Raman Global University
-
Jun 29, 2026, 12:35Dilini Christina Ranasinghe: Behind Every Unit of Blood
-
Jun 29, 2026, 06:48Christina Pohlman: Anticoagulants and Bone Health – APS Awareness Month Day 23
-
Jun 29, 2026, 06:33Andreas Calatzis: Can Fibrinolysis Sensitivity Be Claimed Without a Reference Standard
-
Jun 29, 2026, 06:25Aliaa Albadri: When a Hair Wash Leads to a Stroke Workup
-
Jun 29, 2026, 06:22Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin